Sodium-Glucose Transporter 2 Inhibitors

Preferred Label : Sodium-Glucose Transporter 2 Inhibitors;

MeSH definition : Compounds that inhibit SODIUM-GLUCOSE TRANSPORTER 2. They lower blood sugar by preventing the reabsorption of glucose by the kidney, and are used in the treatment of TYPE 2 DIABETES MELLITUS.; Compounds that inhibit SODIUM-GLUCOSE TRANSPORTER 2. They lower blood sugar by preventing the reabsorption of glucose by the kidney and are used in the treatment of TYPE 2 DIABETES MELLITUS.;

MeSH synonym : Sodium Glucose Transporter 2 Inhibitors; SGLT2 Inhibitors; SGLT-2 Inhibitors; SGLT 2 Inhibitors; Gliflozins; Sodium-Glucose Transporter 2 Inhibitor; Sodium Glucose Transporter 2 Inhibitor; Gliflozin; SGLT-2 Inhibitor; Inhibitor, SGLT-2; SGLT 2 Inhibitor; SGLT2 Inhibitor; Inhibitor, SGLT2;

Details

Origin ID

D000077203;

UMLS CUI

C3273807;

ATC code(s)
- Sodium-glucose co-transporter 2 (SGLT2) inhibitors [ATC Code]
Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- analysis [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
Automatic exact mappings (from CISMeF team)
- Product containing sodium glucose cotransporter subtype 2 inhibitor (product) [SNOMED CT concept]
- SGLT2 Inhibitor [NCIt concept]
- Sodium-glucose co-transporter 2 (SGLT2) inhibitors [ATC Code]
- Sodium-glucose co-transporter 2 inhibitors [ICD-11 Extension code]
- Substance with sodium glucose cotransporter subtype 2 inhibitor mechanism of action (substance) [SNOMED CT concept]
MeSH Descriptor(s) used for indexing
- Sodium-Glucose transporter 2 [MeSH Descriptor]
Metaterm(s)
- endocrinology [CISMeF Metaterm]
Record concept(s)
- Sodium-Glucose Transporter 2 Inhibitors [MeSH concept]
See also (suggested by CISMeF)
- dapagliflozin [MeSH concept]
Semantic type(s)
- Organic Chemical [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
Substance(s)
- (2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol [MeSH Supplementary Concept]
- 6-((4-ethylphenyl)methyl)-3',4',5',6'-tetrahydro-6'-(hydroxymethyl)spiro(isobenzofuran-1(3H),2'-(2H)pyran)-3',4',5'-triol [MeSH Supplementary Concept]
- Canagliflozin [MeSH Descriptor]
- dapagliflozin [MeSH Supplementary Concept]
- empagliflozin [MeSH Supplementary Concept]
- ertugliflozin [MeSH Supplementary Concept]
- ipragliflozin [MeSH Supplementary Concept]
- licogliflozin [MeSH Supplementary Concept]
- remogliflozin etabonate [MeSH Supplementary Concept]
- sergliflozin etabonate [MeSH Supplementary Concept]
UMLS correspondences (same concept)
- SGLT2 Inhibitor [NCIt concept]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients